Wednesday, August 24, 2022 1:20:19 PM
New York Yankees and Duke Basketball
Recent NERV News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:25:30 PM
- Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 05/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:04:42 PM
- Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 11:30:30 AM
- Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates • GlobeNewswire Inc. • 11/07/2023 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 12:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 08:34:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/05/2023 08:33:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 12:58:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/29/2023 12:57:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 08:05:53 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2023 01:28:57 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/15/2023 01:26:55 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/15/2023 01:25:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/09/2023 09:12:02 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/04/2023 12:07:52 PM
- Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates • GlobeNewswire Inc. • 08/01/2023 11:30:39 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2023 11:01:16 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 07/07/2023 08:18:56 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM